20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9020 | GSK620 | Epigenetic Reader Domain | |
GSK620 is a pan-BD2 inhibitor, which shows an anti-inflammatory phenotype in human whole blood with excellent broad selectivity, developability, and in vivo oral pharmacokinetics.GSK620 is highly selective for the BET-BD... | |||
T22408 | Proflavine | 3,6-Diaminoacridine | Antibacterial |
Proflavine (3,6-Diaminoacridine) (3,6-Diaminoacridine) is a disinfectant bacteriostatic against many gram-positive bacteria and is a topical antiseptic used mainly in wound dressings. | |||
T12997 | SR-318 | p38 MAPK , TNF | |
SR-318 is a potent and highly selective inhibitor of p38 MAPK(IC50s of 5 nM, 32 nM and 6.11 μM for p38α, p38β and p38α/β, respectively), has anti-cancer and anti-inflammatory activity. | |||
T8372 | VU0134992 | VU 0134992 | Potassium Channel |
VU0134992 is an Kir4.1 blocker with an IC50 value of 0.97 μM | |||
T13316 | VU0134992 hydrochloride | Potassium Channel | |
VU0134992 hydrochloride is the first subtype-preferring, orally active and selective blocker of Kir4.1 potassium channel pore(IC50 : 0.97 µM). | |||
T0438 | Proflavine Hemisulfate | 3,6-Diaminoacridine hemisulfate,Proflavin hemisulfate | Others , Potassium Channel , DNA , Thrombin , Antibacterial , Autophagy |
Proflavine Hemisulfate (3,6-Diaminoacridine hemisulfate) is the hemisulfate salt form of proflavine, an acridine-derived fluorescent contrast and disinfectant agent that can potentially be used for cellular imaging and a... | |||
T14975 | CJ-42794 | CJ-042794 | Others |
CJ-42794 (CJ-042794) is a selective antagonist of prostaglandin E receptor subtype 4 (EP4). It inhibits [3H]-PGE2 binding to the human EP4 receptor (a mean pKi: 8.5). CJ-42794 is a binding affinity that was at least 200-... | |||
T6658 | SB-408124 | OX Receptor | |
SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor. | |||
TN2079 | (-)-Pinoresinol | Others , TNF , NF-κB , COX | |
(-)-Pinoresinol is isolated from the whole plant of Serissa japonica (Thunb.) Thunb. | |||
T32824 | LM-1685 | LM 1685,LM1685 | COX |
LM-1685 is a potent and selective inhibitor of COX-2 IN human monocytes and whole blood with IC50 of 0.65µM and IC50 = 4.3μM, respectively, and is a potential compound for the treatment of inflammation. | |||
T3S0693 | Blinin | Others | |
Blinin, isolated from the whole plant of Conyza blinii, is used in folk medicine in the south-west of China. | |||
TN7077 | Sinocrassoside C1 | Others | |
Sinocrassoside C1 is the methanolic extract of the whole plant of Sinocrassula indica (Crassulaceae), six new flavonol glycosides | |||
T31213 | Dazmegrel | UK-38,485,UK 38485,UK 38,485,UK38,485,UK-38485 | PPAR |
Dazmegrel (UK 38,485) is a potent and specific thromboxane A2 (TXA2) synthase inhibitor for the prevention of increased whole platelet aggregation in normal pregnancy. | |||
T5730 | MALTOHEXAOSE | Amylohexaose | Others , Endogenous Metabolite |
Maltohexaose (Amylohexaose) is a natural saccharide, and can be produced from amylose, amylopectin and whole starch. | |||
T10866 | Cot inhibitor-2 | TNF , MAPK | |
Cot inhibitor-2 is a cot (Tpl2/MAP3K8) inhibitor (IC50: 1.6 nM) with potency, selectivity and oral activity. cot inhibitor-2 inhibits LPS-stimulated TNF-α production in human whole blood with an IC50 of 0.3 μM. | |||
T4367 | Mycro 3 | Mycro-3 | c-Myc , Autophagy |
Mycro 3 is potent and selective for c-Myc in whole cell assays. | |||
T77747 | Adecatumumab | MT 201 | Others |
Adecatumumab (MT201) is a whole-person IgG1 monoclonal antibody to human EpCAM. Adecatumumab has potential anticancer activity and can be used to study breast cancer. | |||
T77018 | Garadacimab | CSL312 | Factor Xa |
Garadacimab (CSL312) is a potent whole-human IgG4 monoclonal antibody targeting activation factor XII (FXIIa). Garadacimab can be used to study hereditary angioedema. | |||
T76874 | Erenumab | AMG-334 | CGRP Receptor |
Erenumab is a whole-human monoclonal antibody. Erenumab inhibits calcitonin gene-related peptide (CGRP) receptors. Erenumab can be used to prevent migraine attacks. | |||
T2758 | Madecassic acid | 6-Deoxy-L-Galactose,L-Fucose,Brahmic acid,L-fucopyranose | Others , TNF , COX , NO Synthase , Interleukin |
Madecassic acid (L-fucopyranose) is extracted from the whole herb of Centella asiatica. |